0001213900-26-049602.txt : 20260429 0001213900-26-049602.hdr.sgml : 20260429 20260429213642 ACCESSION NUMBER: 0001213900-26-049602 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250911 FILED AS OF DATE: 20260429 DATE AS OF CHANGE: 20260429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xu Jiandong CENTRAL INDEX KEY: 0001920399 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40608 FILM NUMBER: 26919528 MAIL ADDRESS: STREET 1: C/O DENALI CAPITAL ACQUISITION CORP. STREET 2: 437 MADISON AVENUE, 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Estrella Immunopharma, Inc. CENTRAL INDEX KEY: 0001844417 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 861314502 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 370 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 318-9098 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 370 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: TradeUP Acquisition Corp. DATE OF NAME CHANGE: 20210204 4 1 ownership.xml X0609 4 2025-09-11 0 0001844417 Estrella Immunopharma, Inc. ESLA 0001920399 Xu Jiandong false C/O ESTRELLA IMMUNOPHARMA, INC. 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608 0 1 0 0 Chief Financial Officer 0 Common Stock, par value $0.0001 per share 2025-09-11 4 P 0 100 1.04 A 264588 D Common Stock, par value $0.0001 per share 2025-09-22 4 P 0 1000 1.16 A 16700 I By Spouse Common Stock, par value $0.0001 per share 2025-10-07 4 P 0 1000 1.33 A 265488 D Held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ Jiandong Xu 2026-04-29